Compositions containing therapeutically active components having enhanced solubility

  • US 6,562,873 B2
  • Filed: 07/10/2001
  • Issued: 05/13/2003
  • Est. Priority Date: 07/14/2000
  • Status: Expired due to Term
First Claim
Patent Images

1. A composition comprising:

  • a therapeutically active component selected from the group consisting of alpha-2-adrenergic agonists and mixtures thereof, and being present in an amount effective to provide a desired therapeutic benefit to a patient to whom the composition is administered;

    a solubility enhancing component, other than a cyclodextrin, in an amount effective to increase the solubility of the therapeutically active component in the composition relative to the solubility of an identical therapeutically active component in a similar composition without the solubility enhancing component;

    an oxy-chloro component in an effective amount to at least aid in preserving the composition; and

    a liquid carrier component.

View all claims

    Thank you for your feedback